BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2866855)

  • 1. The interaction of human pancreatic growth hormone releasing factor 1-44 with somatostatin in vivo in normal man.
    Davies RR; Turner SJ; Orskov H; Johnston DG
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):271-6. PubMed ID: 2866855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma growth hormone, somatostatin, insulin and glucagon inter-relationships during infusion of human pancreatic growth hormone-releasing factor in young and adult ducks (Anas platyrhynchos).
    Foltzer-Jourdainne C; Harvey S; Karmann H; Mialhe P
    J Endocrinol; 1987 Jul; 114(1):25-32. PubMed ID: 2888829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
    Arosio M; Ambrosi B; Guglielmino L; Faglia G
    J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
    Shimizu T; Inoue K
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration.
    Pieters GF; Smals AE; Hermus AR; Smals AG; Benraad TJ; Kloppenborg PW
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):701-7. PubMed ID: 6150772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
    Cuttler L; Welsh JB; Szabo M
    Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pancreatic growth hormone-releasing factor stimulates release of growth hormone in conscious unrestrained male rabbits.
    Chihara K; Minamitani N; Kaji H; Kodama H; Kita T; Fujita T
    Endocrinology; 1983 Dec; 113(6):2081-5. PubMed ID: 6139274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone response of bull calves to growth hormone-releasing factor.
    Enright WJ; Zinn SA; Chapin LT; Tucker HA
    Proc Soc Exp Biol Med; 1987 Apr; 184(4):483-8. PubMed ID: 3104919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man.
    Davis JR; Sheppard MC; Shakespear RA; Lynch SS; Clayton RN
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):135-40. PubMed ID: 2871948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.
    Hindmarsh PC; Brain CE; Robinson IC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):353-60. PubMed ID: 1684314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of normal subjects and patients with idiopathic growth hormone deficiency to continuous infusion of human pancreatic growth hormone releasing factor 1-44.
    Davies RR; Turner SJ; Parkin JM; Johnston DG
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):569-74. PubMed ID: 6437706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of human pancreatic growth hormone-releasing factor, thyrotropin-releasing hormone, and somatostatin on growth hormone release in chickens.
    Taylor JE; Ball CA; Leung FC
    Proc Soc Exp Biol Med; 1986 Dec; 183(3):363-7. PubMed ID: 2879290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1-44 in normal man.
    Davies RR; Turner S; Johnston DG
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):477-81. PubMed ID: 6439436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
    Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.
    Vance ML; Borges JL; Kaiser DL; Evans WS; Furlanetto R; Thominet JL; Frohman LA; Rogol AD; MacLeod RM; Bloom S
    J Clin Endocrinol Metab; 1984 May; 58(5):838-44. PubMed ID: 6423660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pancreatic growth hormone releasing factor (hpGRF): GRF- and GH-levels after bolus injection and infusion of hpGRF.
    von Werder K; Losa M; Stalla GK; Bock L; Müller OA
    Acta Neurochir (Wien); 1985; 75(1-4):81-7. PubMed ID: 2986424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pancreatic tumor GH-releasing factor.
    Thorner MO; Evans WS; Vance M; Borges JL; Blizzard RM; Rogol AD; MacLeod RM; Cronin MJ; Frohman LA; Thominet JL
    Acta Neurochir (Wien); 1985; 75(1-4):72-80. PubMed ID: 2986423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravenous administration of growth hormone-releasing factor (hpGRF-44) and Tyr-D-Trp-Ala-Trp-D-Phe-NH2 on plasma hormones and metabolites in goats.
    Hart IC; James S; Perry BN; Simmonds AD
    J Endocrinol; 1984 Nov; 103(2):173-8. PubMed ID: 6436424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of an adenylate cyclase dually regulated by somatostatin and human pancreatic growth hormone (GH)-releasing factor in GH-secreting cells.
    Spada A; Vallar L; Giannattasio G
    Endocrinology; 1984 Sep; 115(3):1203-9. PubMed ID: 6146515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.